BDBM50073048 2-[4-(2-Oxo-2,3-dihydro-benzoimidazol-1-yl)-piperidin-1-yl]-N-(9-oxo-9H-fluoren-3-yl)-acetamide::CHEMBL62166

SMILES O=C(CN1CCC(CC1)n1c2ccccc2[nH]c1=O)Nc1ccc2C(=O)c3ccccc3-c2c1

InChI Key InChIKey=ZWPVDHAWHOQDPJ-UHFFFAOYSA-N

Data  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50073048   

TargetNeuropeptide Y receptor type 1(RAT)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073048(2-[4-(2-Oxo-2,3-dihydro-benzoimidazol-1-yl)-piperi...)
Affinity DataIC50: >5.00E+3nMAssay Description:The compound was tested for the binding affinity against NPY1 (Neuropeptide Y receptor type 1)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 2(RAT)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073048(2-[4-(2-Oxo-2,3-dihydro-benzoimidazol-1-yl)-piperi...)
Affinity DataIC50: >5.00E+3nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073048(2-[4-(2-Oxo-2,3-dihydro-benzoimidazol-1-yl)-piperi...)
Affinity DataIC50:  0.470nMAssay Description:Binding affinity of the compound against human Neuropeptide Y receptor type 5 in HEK 293 cell line by using [125I]-PYY as radioligandMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 4(RAT)
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073048(2-[4-(2-Oxo-2,3-dihydro-benzoimidazol-1-yl)-piperi...)
Affinity DataIC50: >5.00E+3nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
The R. W. Johnson Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50073048(2-[4-(2-Oxo-2,3-dihydro-benzoimidazol-1-yl)-piperi...)
Affinity DataIC50:  0.470nMAssay Description:The compound was tested for the binding affinity against Neuropeptide Y receptor type 5 in ratMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed